Disease Markers

Table of Contents: 2023

  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9841329
  • - Retraction

Retracted: Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9826918
  • - Retraction

Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9824032
  • - Retraction

Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9809678
  • - Retraction

Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9807093
  • - Retraction

Retracted: Long Noncoding RNA SBF2-AS1 Promotes Abdominal Aortic Aneurysm Formation through the miRNA-520f-3p/SMARCD1 Axis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9793869
  • - Retraction

Retracted: Comparison of Short-Term Restorative Effects and Periodontal Health Status of Restorations Made of Different Materials in Full-Crown Restoration of Mandibular Premolar Tooth Defects

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9791613
  • - Retraction

Retracted: Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9786805
  • - Retraction

Retracted: Calycosin Inhibits the Malignant Behaviors of Lung Adenocarcinoma Cells by Regulating the circ_0001946/miR-21/GPD1L/HIF-1α Signaling Axis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9785270
  • - Retraction

Retracted: Effects of Individualized Nursing Based on Zero-Defect Theory on Perioperative Patients Undergoing Laparoscopic Cholecystectomy

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9765649
  • - Retraction

Retracted: Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9762735
  • - Retraction

Retracted: Effects of Fluid Shear Stress on Human Intervertebral Disc Nucleus Pulposus Cells Based on Label-Free Quantitative Proteomics

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9898020
  • - Retraction

Retracted: Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9897082
  • - Retraction

Retracted: PTPN11 Gene Mutations and Its Association with the Risk of Congenital Heart Disease

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9893065
  • - Retraction

Retracted: Functional Analysis of Serum Long Noncoding RNAs in Patients with Atrial Fibrillation

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9876090
  • - Retraction

Retracted: Effect of HIV-1 Protease Inhibitor on IL-18 and IL-1β in Rats with Insulinoma

Disease Markers
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.